Summary
Updated Aug 31, 2026
Christopher Benecchi is Chief Operating Officer of Sage Therapeutics, Inc. (SAGE). 2 SEC Form 4 filings on record going back to 2024, most recently on 31 July 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Christopher Benecchi has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Christopher Benecchi go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Christopher Benecchi's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Nello Mainolfi - $34.88M of KYMR open-market activity in the last 12 months
- James C. Foster - $34.84M of CRL open-market activity in the last 12 months
- Third Rock Ventures V, L.P. - $34.39M of RAPP open-market activity in the last 12 months
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Michael B. Petras Jr. - $33.51M of SHC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher Benecchi?
Christopher Benecchi is a corporate insider, tracked as Chief Operating Officer of Sage Therapeutics, Inc. (SAGE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Benecchi last file a Form 4?
The most recent primary Form 4 on record is dated 31 July 2025, one of 2 filings going back to 2024.
Where can I see all of Christopher Benecchi's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher Benecchi and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial